Crossmark

Persistence of High In Vivo Efficacy and Safety of Artesunate–Amodiaquine and Artemether–Lumefantrine as the First- and Second-Line Treatments for Uncomplicated Plasmodium falciparum Malaria 10 Years After Their Implementation in Gabon

Crossref DOI link: https://doi.org/10.2478/s11686-019-00115-y

Published Online: 2019-09-11

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ndong Ngomo, Jacques M.

Ondzagha Megnie, Guy J.

Moutombi Ditombi, Bridy

Koumba Lengongo, Jeanne V.

M’Bondoukwé, Noé P.

Offouga, Christelle L.

Mawili-Mboumba, Denise P.

Lekana-Douki, Jean B.

Ringwald, Pascal

Fandeur, Thierry

Bouyou-Akotet, Marielle K.
License Information

Text and Data Mining valid from 2019-09-11

Version of Record valid from 2019-09-11
More Information

Article History

Received: 18 September 2018

Accepted: 16 August 2019

First Online: 11 September 2019

Change Date: 11 October 2019

Change Type: Correction

Change Details: Unfortunately two errors appeared in this article.

Updates are available Correction dated 2019-10-11

Click to view Correction: https://doi.org/10.2478/s11686-019-00132-x